Rezultati pretraživanja
  1. 18. pro 2019.

    Developed for the treatment of , inarigivir is an orally-available selective immunomodulator that stimulates the innate immune response and inhibits viral replication. Watch this video to learn more :

  2. 12. pro 2019.

    SWEET GAP TO $1.75 AWESOME LOADING AREA-CHART @ 5 YEAR LOWS! 💫OVER 800,000 MEMBERS NOW! 💫PATENT PENDING TECH THAT RIVALS AND HUGE BIG TECH INTEGRATIONS 💫OVER 60 MLM CLIENTS WITH RECURRING REVENUE AND BACKLOG

  3. 26. stu 2019.

    Inarigivir, our most advanced product candidate, has the potential to provide a functional cure for . Watch this video to learn more about inarigivir’s novel mechanism of action :

  4. 12. stu 2019.

    fantastic video on inarigivir and why an immunomodulator can be a key combo drug for treating . 's $16 price target can be seen at Expecting to see more deals soon.

  5. 7. srp 2019.

    Learn about our strategies, learn how to find low-risk timing points and devlop a safe systematic process to gain a statisical edge in the market. Check it out here:

  6. 7. srp 2019.

    Learn a safe and effective approach to with step-by-step instruction, daily webinars, and a supportive community. Trade with less emotion, no guesswork, and more direction:

  7. 3. srp 2019.
  8. 22. svi 2019.
  9. 27. kol 2018.
  10. 9. kol 2018.
  11. 21. lip 2018.
  12. 26. lis 2017.

    Inarigivir's dual anti-viral mechanisms are designed to promote viral clearance and inhibit viral replication:

  13. 16. kol 2017.
  14. 15. kol 2017.
  15. 20. srp 2017.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.